The latter harmful effects may be due to the artifacts of transgenic gene overexpression, since utilizing recombinant ACE2 protein for therapeutic models has been recently shown to be beneficial in various disease models (Oudit et al., 2010; Treml et al., 2010; Wysocki et al., 2010) .